280 Participants Needed

Antenatal Milk Expression Education for Breastfeeding

(PREPARE Trial)

JD
MG
Overseen ByMelissa Glasser, PhD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this randomized controlled trial is to examine the impact of a remotely-delivered antenatal milk expression (AME) intervention versus an attention control condition on breastfeeding outcomes among a sample of 280 nulliparous, non-diabetic women with pre-pregnancy body mass indices ≥ 25. AME involves milk expression and collection in the third pregnancy trimester and is theorized to address multiple barriers to breastfeeding among women with higher BMI, including impaired breastfeeding self-efficacy, insufficient milk supply (critical period endocrine modulation of milk volume), and early formula supplementation in the context of a medically complex birth (availability of banked antenatal milk). Participants will be enrolled in their third trimester of pregnancy and allocated into one of two study arms: 1) AME instruction delivered by remote, live International Board Certified Lactation Consultants via an innovative app-based telelactation platform; or 2) an attention control condition (video-based infant care education unrelated to infant feeding). Video-based education for both groups will occur in weekly study visits from 37 to 40 weeks gestation, with women in the intervention group continuing AME 1-2 times per day at home. Measured outcomes of interest will include short and long-term breastfeeding practices (e.g., breastfeeding duration, exclusivity) and participants' experiences with and perceptions of AME.

Research Team

JD

Jill Demirci, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for first-time pregnant women with a BMI ≥ 25, interested in breastfeeding, between 34-36 weeks of pregnancy. They must plan to give birth at certain hospitals and speak English. Women with plans for early delivery, breast surgery history, or diabetes are excluded.

Inclusion Criteria

You plan to breastfeed or are interested in breastfeeding after giving birth.
I am between 34 and almost 37 weeks pregnant.
I plan to have my prenatal care and delivery at a specific hospital that shares electronic medical records.
See 4 more

Exclusion Criteria

I have diabetes that started before or during pregnancy.
I have had breast reduction surgery or radiation.
indication for delivery by 37 weeks gestation
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Antenatal Milk Expression (AME) Intervention

Weekly video interactions with lactation consultants to teach and reinforce antenatal milk expression, with at-home practice of hand expression and collection of expressed milk

4 weeks
4 visits (virtual)

Postpartum Follow-up

Participants are monitored for breastfeeding outcomes, including self-efficacy, exclusivity, and duration

12 months

Treatment Details

Interventions

  • AME
  • Video-based infant care education
Trial Overview The study compares two groups: one learns antenatal milk expression (AME) via an app from lactation consultants; the other gets video-based infant care education not about feeding. The goal is to see if AME helps women with higher BMI overcome breastfeeding challenges.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Antenatal Milk Expression (AME) Intervention GroupExperimental Treatment1 Intervention
Weekly video interactions (weeks 37-40 of pregnancy) with International Board Certified Lactation Consultants (IBCLCs) to teach and reinforce antenatal milk expression. At-home practice of hand expression and collection of any expressed milk.
Group II: Video-based Infant Care Education Control GroupActive Control1 Intervention
Weekly video education (weeks 37-40 of pregnancy) on various topics related to infant care (e.g., safe sleep, car seat safety, etc.).

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security